LeMaitre to Present at the Goldman Sachs Virtual Global Healthcare Conference

Rhea-AI Summary

LeMaitre Vascular (Nasdaq:LMAT) announced that President David Roberts will present at the Goldman Sachs 42nd Annual Virtual Global Healthcare Conference on June 10, 2021, at 5:30 PM ET. The company specializes in devices, implants, and services for peripheral vascular disease, affecting over 200 million people globally. LeMaitre develops and markets vascular devices tailored to vascular surgeons.

BURLINGTON, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Goldman Sachs 42nd Annual Virtual Global Healthcare Conference on Thursday, June 10, 2021, at 5:30 PM ET.

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

FAQ

When is LeMaitre Vascular's presentation at the Goldman Sachs Healthcare Conference?

LeMaitre Vascular's presentation is scheduled for June 10, 2021, at 5:30 PM ET.

What is LeMaitre Vascular's primary focus in healthcare?

LeMaitre Vascular focuses on devices, implants, and services for treating peripheral vascular disease.

What is the stock symbol for LeMaitre Vascular?

The stock symbol for LeMaitre Vascular is LMAT.

How many people are affected by peripheral vascular disease worldwide?

Peripheral vascular disease affects over 200 million people worldwide.